Last Price
0.027
Today's Change
-0.001 (3.57%)
Day's Change
0.026 - 0.029
Trading Volume
5,872,406
Market Cap
73 Million
Shares Outstanding
2 Billion
Avg Volume
15,457,667
Avg Price (50 Days)
0.04
Avg Price (200 Days)
0.04
PE Ratio
-2.70
EPS
-0.01
Earnings Announcement
20-Feb-2025
Previous Close
0.03
Open
0.03
Day's Range
0.026 - 0.029
Year Range
0.015 - 0.099
Trading Volume
5,872,406
1 Day Change
-3.57%
5 Day Change
8.00%
1 Month Change
-30.77%
3 Month Change
-63.51%
6 Month Change
-5.60%
Ytd Change
30.36%
1 Year Change
30.36%
3 Year Change
-75.22%
5 Year Change
-27.30%
10 Year Change
-32.50%
Max Change
-95.89%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.